Department of Palliative Medicine, National Cancer Center, Tokyo, Japan.
Department of Palliative and Supportive Medicine, Graduate School of Medicine, Aichi Medical University, Aich, Japan.
J Palliat Care. 2022 Apr;37(2):107-112. doi: 10.1177/0825859720951356. Epub 2020 Aug 17.
There are no validated tools for measuring eating-related distress among patients with advanced cancer. The aim of the study was to investigate the potential measurement properties of a questionnaire for eating-related distress. This is a secondary analysis. We performed an exploratory factor analysis for factorial validity and calculated Cronbach's α for internal consistency. Patients were classified into the 2 groups categorized using the international cachexia criteria. The total scores of each factor and all items calculated, and comparisons were performed for known-group validity. We performed statistical correlation analysis for concurrent validity, convergent validity, and discriminant validity using Pearson's product moment correlation coefficient. A total of 140 patients responded. Three factors were identified. The values of Cronbach's α were 0.90, 0.89, and 0.86, respectively. Patients were classified into 2 groups: Non-cachexia/Pre-cachexia (n = 57) and Cachexia/Refractory cachexia (n = 83). Significant differences were observed in the total scores of each factor and all items: (factor 1) 7.5 vs. 11.0, p < 0.001; (factor 2) 8.0 vs. 13.0, p < 0.001; (factor 3) 5.0 vs. 10.0, p < 0.001; (all items) 20.0 vs. 35.0, p < 0.001, respectively. The total scores of each factor and all items significantly correlated with the Edmonton Symptom Assessment System-revised and the nutrition impact symptoms: 0.62 (p < 0.001) and 0.63 (p < 0.001), respectively. Scaling success rates were 100% in factor 1, 2, and 3. The questionnaire appears to be useful. Eating-related distress in patients with advanced cancer had 3 factors.
目前尚无针对晚期癌症患者进食相关困扰的有效评估工具。本研究旨在探究一种进食相关困扰问卷的潜在测量性能。这是一项二次分析研究。我们进行了探索性因子分析以评估因子有效性,并计算了内部一致性的 Cronbach's α 值。根据国际恶液质标准对患者进行分类,将其分为两组。计算了每个因子和所有项目的总分,并进行了组间比较以评估其区分度。我们采用 Pearson 乘积矩相关系数进行了统计相关性分析,以评估其同时效度、聚合效度和区分效度。共 140 例患者应答。识别出 3 个因子。Cronbach's α 值分别为 0.90、0.89 和 0.86。患者被分为两组:非恶液质/恶液质前期(n=57)和恶液质/难治性恶液质(n=83)。在每个因子和所有项目的总分方面均观察到显著差异:(因子 1)7.5 分比 11.0 分,p<0.001;(因子 2)8.0 分比 13.0 分,p<0.001;(因子 3)5.0 分比 10.0 分,p<0.001;(所有项目)20.0 分比 35.0 分,p<0.001。每个因子和所有项目的总分均与 Edmonton 症状评估系统修订版和营养影响症状显著相关:0.62(p<0.001)和 0.63(p<0.001)。因子 1、2 和 3 的量表成功率均为 100%。该问卷似乎有用。晚期癌症患者的进食相关困扰可分为 3 个因子。